Skip to Content
Merck
  • Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease.

Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2012-06-23)
Jorge A Zavala, Renato P Munhoz, Hélio A G Teive
ABSTRACT

Pramipexole is a non-ergot dopamine agonist that is used frequently as a single therapy or in combination for the management of Parkinson's disease. Common side effects are daytime drowsiness, hypotension, hallucinations and compulsive behaviour. We describe a patient who developed severe chronic and extensive lymphoedema after pramipexole was introduced and that resolved after its cessation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
R-(−)-Deprenyl hydrochloride, powder, ≥98% (HPLC)
Selegiline hydrochloride, European Pharmacopoeia (EP) Reference Standard